Cipla Scales Up Remdesivir Production 2-Fold

Cipla, the pharmaceutical company has scaled up the production of remdesivir by 2 times from the last wave of the pandemic.

"Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network, to service the demand," the company said in a statement.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘As the demand for the drug surges, the government has prohibited the exports of remdesivir injection and its active pharmaceutical ingredients (API).’

Tweet it Now

"To ensure fair and equitable access, we are working with the regulatory authorities to restrict supply of the drug only to hospital channels and especially those regions with high burden of severe Covid-19," Cipla said.

On Tocilizumab, the company said that given the spike in cases and surge in demand, it is facing a shortage and working closely with its partner in taking necessary steps to ensure availability of the drug.

"We expect intermittent supplies as the demand outstrips supply with some more receipts at the earliest," it added.

COVID-19: Diet Plan and Lifestyle Modifications for the Unlock Phase
Healthy eating habits and adherence to physical activity are required during COVID-19 lockdown. WHO has prepared a set of general tips that you could follow during the lockdown to stay fit and healthy.

Source-IANS

COVID Update: Remdesivir Should be Available to Every Patient
The Gujarat High Court on Monday pulled up the government to provide Remdesivir to all patients and to set up accountability at every booth level to keep a check on the outbreak.

Researchers Suggest Proper usage of Remdesivir for COVID-19
Pharmaceutical scientist sees potential problems with Remdesivir as a COVID-19 treatment.